Role of Galectins in Tumors and in Clinical Immunotherapy
AbstractGalectins are glycan-binding proteins that contain one or two carbohydrate domains and mediate multiple biological functions. By analyzing clinical tumor samples, the abnormal expression of galectins is known to be linked to the development, progression and metastasis of cancers. Galectins also have diverse functions on different immune cells that either promote inflammation or dampen T cell-mediated immune responses, depending on cognate receptors on target cells. Thus, tumor-derived galectins can have bifunctional effects on tumor and immune cells. This review focuses on the biological effects of galectin-1, galectin-3 and galectin-9 in various cancers and discusses anticancer therapies that target these molecules. View Full-Text
A printed edition of this Special Issue is available here.
Share & Cite This Article
Chou, F.-C.; Chen, H.-Y.; Kuo, C.-C.; Sytwu, H.-K. Role of Galectins in Tumors and in Clinical Immunotherapy. Int. J. Mol. Sci. 2018, 19, 430.
Chou F-C, Chen H-Y, Kuo C-C, Sytwu H-K. Role of Galectins in Tumors and in Clinical Immunotherapy. International Journal of Molecular Sciences. 2018; 19(2):430.Chicago/Turabian Style
Chou, Feng-Cheng; Chen, Heng-Yi; Kuo, Chih-Chi; Sytwu, Huey-Kang. 2018. "Role of Galectins in Tumors and in Clinical Immunotherapy." Int. J. Mol. Sci. 19, no. 2: 430.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.